FDA Inspection 1037662 — NorMed

NorMed — FEI 3013226

The FDA completed an inspection of NorMed on January 16, 2018 in Tukwila, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 16, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tukwila, WA (United States)

Citations

IDCFRDescription
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
434221 CFR 211.142(b)Storage under appropriate conditions